Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Delcath Systems Inc (DCTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3,942
  • Shares Outstanding, K 13,594
  • Annual Sales, $ 2,720 K
  • Annual Income, $ -45,120 K
  • 60-Month Beta 0.76
  • Price/Sales 2.53
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 6.48
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/22/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2500 +16.00%
on 03/01/19
0.3400 -14.71%
on 03/15/19
+0.0020 (+0.69%)
since 02/20/19
3-Month
0.2500 +16.00%
on 03/01/19
0.3999 -27.48%
on 12/26/18
+0.0210 (+7.81%)
since 12/20/18
52-Week
0.2300 +26.09%
on 12/20/18
10.3000 -97.18%
on 09/19/18
-5.6600 (-95.13%)
since 03/20/18

Most Recent Stories

More News
Delcath Joins the Ocular Melanoma Community in Recognizing Rare Disease Day

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, highlights the experiences of patients with ocular melanoma...

DCTH : 0.2900 (-3.49%)
Delcath Announces Health Authority Approval for CHEMOSAT in Brazil

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company has received medical device approval...

DCTH : 0.2900 (-3.49%)
Delcath Announces Acceptance of Abstract for Oral Presentation at ECIO 2019

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces an abstract from a prospective phase 2 study conducted...

DCTH : 0.2900 (-3.49%)
Biotech Stocks to Watch

HENDERSON, NV / ACCESSWIRE / February 5, 2019 / In January, the trend in biotech stocks appeared to be on a positive sloping trajectory as the IBB capped off its strongest month in almost a year. Below...

CRON : 21.41 (+0.71%)
CARA : 19.51 (+0.72%)
DCTH : 0.2900 (-3.49%)
EYEN : 5.54 (+0.73%)
Best Ways to Play Biotech Rally

HENDERSON, NV / ACCESSWIRE / January 23, 2019 / The market reached a level toward the end of last year where investors and analysts were throwing the "R" word (recession) around. The cause of this bearish...

CLDX : 4.84 (+1.04%)
GNMX : 0.23 (+4.17%)
GERN : 1.84 (+3.95%)
DCTH : 0.2900 (-3.49%)
HSGX : 0.14 (-4.68%)
Biotech Stocks on the Move

HENDERSON, NV / ACCESSWIRE / January 21, 2019 / Biotech has been one of the hottest sectors this month. Investors are intrigued by the increase in M&A. Now's a great time to start researching some oversold...

TCON : 1.59 (+4.28%)
TYME : 2.28 (-0.44%)
ZIOP : 4.28 (+3.63%)
DCTH : 0.2900 (-3.49%)
MNKD : 2.19 (-0.90%)
Biotech Companies to Watch

HENDERSON, NV / ACCESSWIRE / January 10, 2019 / Biotech has started 2019 off with a bang. Below are a few that you should be paying attention to.

AMRN : 18.82 (-1.00%)
DCTH : 0.2900 (-3.49%)
Biotech Stocks Set to Start 2019 Off with a Bang

HENDERSON, NV / ACCESSWIRE / January 4, 2019 / Biotech companies could be in store for a big 2019, and investors are starting to take notice. The stocks we are highlighting today all look poised for a...

CRON : 21.41 (+0.71%)
VKTX : 8.40 (+1.57%)
NVAX : 0.64 (+2.77%)
DCTH : 0.2900 (-3.49%)
CBD and Biotech Plays on The Rise

HENDERSON, NV / ACCESSWIRE / December 11, 2018 / We have found several companies releasing recent news we believe should be on your radar.

KSHB : 5.6700 (+0.71%)
MPXEF : 0.7990 (-13.15%)
DCTH : 0.2900 (-3.49%)
Growth Opportunities in Stocks Coming Off of Bottoms

HENDERSON, NV / ACCESSWIRE / November 27, 2018 / With the market in a bit of a swoon, many companies with positive 3rd quarter announcements have not yet seen them baked into the share price properly....

VKTX : 8.40 (+1.57%)
EMHTF : 3.2800 (-5.20%)
NWBO : 0.2945 (-7.39%)
OGRMF : 7.2700 (+4.30%)
DCTH : 0.2900 (-3.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade DCTH with:

Key Turning Points

2nd Resistance Point 0.3253
1st Resistance Point 0.3077
Last Price 0.2900
1st Support Level 0.2727
2nd Support Level 0.2553

See More

52-Week High 10.3000
Fibonacci 61.8% 6.4533
Fibonacci 50% 5.2650
Fibonacci 38.2% 4.0767
Last Price 0.2900
52-Week Low 0.2300

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar